Xenon gas

DRUG4 trials

Sponsors

Imperial College London, University Hospitals Bristol and Weston NHS Foundation Trust, Eric A. Hoffman

Conditions

Hypoxic Ischaemic EncephalopathyPulmonary Disease, Chronic Obstructive

Early Phase 1

Image and Model Based Analysis of Lung Disease

CompletedNCT03764163

Eric A. HoffmanPulmonary Disease, Chronic Obstructive

Start: 1997-09-30End: 2015-06-05Updated: 2019-01-22

Phase 1

Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth

CompletedNCT01545271

University Hospitals Bristol and Weston NHS Foundation TrustHypoxic Ischaemic Encephalopathy

Start: 2012-05-31End: 2015-03-31Updated: 2022-12-15

Phase 2

Xenon and Cooling Therapy in Babies at High Risk of Brain Injury Following Poor Condition at Birth

CompletedNCT02071394

University Hospitals Bristol and Weston NHS Foundation TrustHypoxic Ischaemic Encephalopathy

Start: 2014-03-31End: 2020-04-15Updated: 2023-01-05

Unknown Phase

Neuroprotective Effects of Hypothermia Combined With Inhaled Xenon Following Perinatal Asphyxia

CompletedNCT00934700

Imperial College LondonHypoxic Ischaemic Encephalopathy

Start: 2012-02-29End: 2014-09-30Updated: 2022-04-21

Related Papers

Moderate hypothermia within 6 h of birth plus inhaled xenon versus moderate hypothermia alone after birth asphyxia (TOBY-Xe): a proof-of-concept, open-label, randomised controlled trial.

2015-12-19143 citations

Safety and feasibility of xenon as an adjuvant to sevoflurane anaesthesia in children undergoing interventional or diagnostic cardiac catheterization: study protocol for a randomised controlled trial

Trials2015-03-0315 citations

Argon neuroprotection.

2010-02-2217 citations